Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Noninvasive detection of any-stage cancer using free glycosaminoglycans | Synapse

December 5, 2022Open Access

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

= 121 and 49 cases). Overall, GAGomes appeared to be powerful MCED metabolic biomarkers, potentially doubling the number of stage I cancers detectable using genomic biomarkers.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Bratulić et al. (Mon,) studied this question.

synapsesocial.com/papers/6a015d7d831589f3542e17ff https://doi.org/https://doi.org/10.1073/pnas.2115328119

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Choosing The Right Animal Model for Renal Cancer Research2020 · 76 citations
2Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening2019 · 709 citations
3Cohort Profile: LifeLines, a three-generation cohort study and biobank2014 · 887 citations
4Glycosaminoglycans: key players in cancer cell biology and treatment2012 · 543 citations
5Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein2015 · 219 citations